Neuromics' Short Overview
0 likes2 views
Neuromics specializes in providing human primary cells and 3-D tissue models for drug discovery and basic research, supported by over 250 peer-reviewed publications. Their products include various human cells, antibodies, and growth factors, with positive customer feedback highlighting product reliability and excellent service. They also offer third-party services and detailed procedures for applications such as permeability studies using their 3-D blood-brain barrier models.
1 of 10
Download to read offline
Ad
Recommended
Neuromics base presentation 2020
Neuromics base presentation 2020Pete Shuster
油
The document outlines Neuromics' offerings in human primary cells, 3D tissue models, and related assays for biomedical research, emphasizing the reliability of their products as evidenced by over 250 peer-reviewed publications. It highlights various human cell types, including astrocytes and endothelial cells used in static blood-brain barrier models, and provides examples of published research utilizing these models. Additionally, it details customer feedback and experiences, showcasing quality service and product satisfaction.Neuromics base presentation 2020 with Virus Transport Media
Neuromics base presentation 2020 with Virus Transport MediaPete Shuster
油
The document provides an overview of various human primary cells, 3-D tissue models, and cell-based assays, emphasizing their utility in research and the strict quality control of their virus transport media (VTM). It highlights numerous peer-reviewed studies utilizing their products, particularly in creating models like the blood-brain barrier and examining drug permeability. Additionally, customer feedback indicates satisfaction with product availability and technical support, reinforcing trust in their results and services.Neuromics base presentation 2019
Neuromics base presentation 2019Pete Shuster
油
The document highlights Neuromics' focus on human primary cells and 3D tissue models used in cell-based assays, showcasing various applications such as the static blood-brain barrier model. It includes feedback from customers and details on multiple peer-reviewed publications related to their products. Additionally, the document emphasizes the reliability of their results and customer support, alongside a call for feedback and inquiries.Neuromics Bases 2 and 3 Cell Based Assays
Neuromics Bases 2 and 3 Cell Based AssaysPete Shuster
油
This document provides information on cell-based assay solutions from Neuromics for drug discovery applications. It describes 3D blood-brain barrier models, extracellular matrixes, coating solutions, and published data from human BBB models. Details are given on human brain astrocytes and endothelial cells, as well as retinal cells. An example is shown of researchers using these cell types to create an in vitro BBB model. The document also discusses FBS and other serum options and provides contact information for Neuromics.Neuromics presentation november 2021
Neuromics presentation november 2021Pete Shuster
油
This document summarizes cell-based assay solutions from Neuromics and its partnership with UB Systems. It describes 3D cell-based assays including blood-brain barrier models and extracellular matrix hydrogels. It also provides details on various human brain cell types such as endothelial cells, astrocytes, and pericytes that can be used to build customized 3D brain models. Additionally, it mentions services offered like media filling and various cell culture reagents including fetal bovine serum in different grades.2 and 3-D Human Cell-Based Assays
2 and 3-D Human Cell-Based AssaysPete Shuster
油
Neuromics and UBC have a business partnership to provide 3D cell-based assay solutions and manufacture and fill media. Neuromics offers proven human cell types like brain astrocytes and endothelial cells for building blood brain barrier models. They also provide fetal bovine serum in different grades based on endotoxin levels as well as other animal sera. Customers have successfully used Neuromics' cells to create static 3D blood brain barrier models.Cell based assays presentation v3_03_2012
Cell based assays presentation v3_03_2012Pete Shuster
油
The document outlines innovative pre-clinical development tools designed to enhance early-phase drug discovery by utilizing physiologically relevant human stem-derived cells and systems, which could lead to reduced animal testing and costs. It highlights the company's proven solutions, extensive customer base, and expert support in high throughput screening, compound testing, and toxicology studies. Additionally, it emphasizes the advantages of human stem cell-derived products, including reproducibility, cost-effectiveness, and technical expertise in cell differentiation.Cell based assays presentation V2_03_2012
Cell based assays presentation V2_03_2012Pete Shuster
油
This document provides an executive overview of a company called Neuromics/Vitro Biopharma that develops pre-clinical tools for drug discovery using human stem cell-derived cell systems. The company offers physiologically relevant human cells and cellular systems to enable better in vitro screening and target identification, reducing animal models and shortening development timelines. Key offerings include human stem cell-derived neuronal cells, glial cells, immune cells and other cell types, specialized media, transfection reagents, markers and labeling technologies. The company aims to improve early drug discovery through more predictive human cell-based assays.Characterization of novel human blood-brain barrier (hCMEC/d3) cell line
Characterization of novel human blood-brain barrier (hCMEC/d3) cell line Debanjan (Deb) Das
油
The document discusses the development and characterization of a novel human blood-brain barrier (BBB) cell line, hCMEC/D3, which aims to enhance CNS drug screening. It outlines the importance of the BBB in drug development, the properties of the hCMEC/D3 cell line, and preliminary studies on its transport and permeability characteristics. The findings indicate that hCMEC/D3 retains key functionalities of BBB, suggesting its potential as a reliable in vitro model for testing pharmaceutical compounds.Poster BrainPlotting SEISC 2017 "Prediction of Human PK data based on innovat...
Poster BrainPlotting SEISC 2017 "Prediction of Human PK data based on innovat...Nicolas Perriere
油
Brainplotting specializes in pharmacokinetics studies of the human brain using a proprietary brain exposure prediction model (BEP). This model leverages primary human in vitro tools to predict in vivo drug concentrations, utilizing physiological models to assess BBB permeability and transport mechanisms. Collaborating with academic partners, the company validates its predictive models using various diseases and drug transport studies.The Blood-Brain Barrier in Neurological Disease
The Blood-Brain Barrier in Neurological DiseaseEvan Wehr
油
The document discusses the blood-brain barrier (BBB) and its implications in neurological diseases, focusing on research conducted using div-BBB cartridges to simulate BBB conditions in vitro. The study found that different levels of stretch in the cartridges affected the permeability of astrocyte cells, confirming that the 0% and 79% stretched cartridges had distinct crossing capabilities. Additionally, recommendations for future studies and enhancements to testing methodologies are provided, aiming to further understand BBB dynamics."Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug DiscoveryPete Shuster
油
The proteosep速 2D protein microarray module facilitates drug discovery by providing clinically relevant data early in the clinical trial process, enabling the identification of high probability targets and patient autoantibody signatures. It is designed for various applications including biologics and biosimilars development, with a focus on using real patient samples to generate unique insights. The microarray can efficiently differentiate patient populations and identify candidate biomarkers for further analysis, supporting disease monitoring and treatment response assessments.Neuromics Presentation V4
Neuromics Presentation V4Pete Shuster
油
The document outlines tools and capabilities for cell-based assays and gene expression analysis in early-phase drug discovery, emphasizing the use of physiologically relevant primary human, rat, and mouse cells to improve in vitro screening, reduce animal model use, and lower costs. It highlights the expertise of Neuromics in supporting pharmaceutical and biotechnology researchers with technical support, protocols, and reproducibility. Examples of applications include neurogenesis, neuronal differentiation, and compound screening using human neural progenitor kits and various assay methodologies.OncoPrime - Neuro
OncoPrime - Neuro Rachna Goyal
油
The document discusses the Onco-Neuroprime TM platform developed by Saarum Sciences for phenotypic drug and biomarker discovery in high grade glioma, highlighting the use of 3D neurospheres derived from patient tumors for drug screening. It presents various assays and characterizations performed on glioma samples, as well as the advantages of using this platform over traditional 2D cell lines. Additionally, it provides insights into the diversity of brain cancer subtypes and the biobank's inventory of patient samples.Central nervous system drug discovery and challenges.pptx
Central nervous system drug discovery and challenges.pptxGaurav Pandey
油
CNS drug discovery is a complex and challenging process due to the intricate nature of neurological disorders and the presence of the blood-brain barrier (BBB), which limits drug penetration. The development of effective therapies faces hurdles such as high failure rates in clinical trials, off-target side effects, and the long timelines required for safety and efficacy testing. Additionally, the complex pathophysiology of CNS diseases makes target identification difficult. Primary Cell e Newsletter Issue 18 (jun 2016) Cell Applications
Primary Cell e Newsletter Issue 18 (jun 2016) Cell ApplicationsDaniel Schroen, PhD
油
The document discusses a study on the accumulation of Alzheimer's disease-associated amyloid-硫 proteins at the blood-brain barrier, leading to cerebral amyloid angiopathy. It highlights the utility of pre-screened bovine brain microvascular endothelial cells (BBMEC) for researching endothelial cell signaling pathways and drug discovery. Additionally, it mentions the significance of using integration-free human induced pluripotent stem cells (iPSCs) to avoid genetic integration issues when studying cell behavior related to the blood-brain barrier.Jem neuroscience special_issue
Jem neuroscience special_issueElsa von Licy
油
The document summarizes recent publications from The Journal of Experimental Medicine focusing on neuroscience. It highlights several studies: one finding that monocyte-derived macrophages initiate myelin destruction in multiple sclerosis, while microglia-derived macrophages clear debris; another activating B-RAF kinase to promote axon regeneration after nerve injury; and one showing that blocking interleukin-21 reduces brain injury following stroke in mice. It also summarizes studies on retinal thinning in frontotemporal dementia and targeting neurovascular pathology in Alzheimer's disease models.A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...InsideScientific
油
The document discusses advancements in using PET/CT imaging for image-guided neurointerventions, emphasizing the delivery and clearance of therapeutic agents to the brain. It compares various delivery methods, including systemic, intra-arterial, and intracerebral routes, highlighting their pros and cons related to effectiveness and invasiveness. Furthermore, it reviews historical data and current studies on the efficacy of these methods, particularly focusing on intra-arterial therapy combined with blood-brain barrier modulation.UCSF Hyperpolarized MR #8-2: Neurological (2019)
UCSF Hyperpolarized MR #8-2: Neurological (2019)Peder Larson
油
The document discusses the integration of hyperpolarized magnetic resonance (MR) into biomedical research focusing on neurological disorders such as Alzheimer's, traumatic brain injury, and multiple sclerosis. It highlights preclinical findings about brain metabolism, inflammation, and cognitive deficits, as well as suggests potential future applications and ongoing clinical trials. Key challenges in utilizing hyperpolarized MR for studying the brain's metabolic processes and monitoring treatment are also addressed.Towards automated phenotypic cell profiling with high-content imaging
Towards automated phenotypic cell profiling with high-content imagingOla Spjuth
油
This document outlines an initiative at Uppsala University to enhance drug discovery through automated phenotypic cell profiling using high-content imaging and AI. The research aims to integrate automation and intelligent experimental design to speed up the hypothesis generation, testing, and data analysis processes in biological labs. Key technologies mentioned include automated labs, advanced imaging techniques, and a focus on data-driven science to optimize drug development and safety assessments.The Blood Brain Barrier, A Bridge Too Far
The Blood Brain Barrier, A Bridge Too FarLaurent Lecanu
油
The document presents challenges in targeting the brain, focusing on the blood-brain barrier (BBB) as a significant barrier to drug delivery due to its unique structure and restrictive characteristics. It highlights the complexities of drug permeability, the role of various transporters, and emerging nanoparticle technologies for overcoming these challenges. Additionally, it addresses the lack of knowledge and integration regarding BBB in pharmaceutical research and development, emphasizing the need for further exploration and mapping in drug design.Several methods making drugs overcome blood-brain barier obstacle .
Several methods making drugs overcome blood-brain barier obstacle .Abeer Abd Elrahman
油
The blood-brain barrier represents a major obstacle to delivering drugs to the central nervous system. Several methods have been attempted to overcome this barrier, including using exosomes, prodrugs, polymer encapsulation, receptor-mediated transport, modifying surface charge, and transiently disrupting the barrier using chemical agents, focused ultrasound, or magnetic fields. Encapsulating drugs within biodegradable polymers like PLGA allows them to accumulate in brain tumors at higher levels compared to healthy brain tissue.Advances-in-cancer-research.pdf
Advances-in-cancer-research.pdfssuser54a9d9
油
The document discusses several technologies and approaches for advancing cancer research by addressing limitations of current methodologies. It describes a new technology called the NanoString GeoMx Digital Spatial Profiler that enables high-plex spatial analysis of biological samples using fluorescently labeled antibodies. It also discusses the development of customized morphology markers to help users select biologically relevant regions of interest for analysis. Additionally, it covers several other areas of cancer research including the use of stem cells for treatment, automated counting of immune cells, development of drug antibodies and therapies targeting GPCRs, and blocking immune checkpoint molecules to stimulate anti-tumor immune responses.Neural surface antigens from basic biology towards biomedical applications 1s...
Neural surface antigens from basic biology towards biomedical applications 1s...tredeitio
油
Neural surface antigens from basic biology towards biomedical applications 1st Edition Pruszak
Neural surface antigens from basic biology towards biomedical applications 1st Edition Pruszak
Neural surface antigens from basic biology towards biomedical applications 1st Edition PruszakHCS for brain disorders / HCS Pharma at B4B mars 2018
HCS for brain disorders / HCS Pharma at B4B mars 2018HCS Pharma
油
HCS Pharma is a biotechnology company focused on high-content screening (HCS) and cellular imagery to facilitate drug discovery and repurposing, especially for brain disorders. Their innovative methods allow for the identification of new drug applications and mechanisms of diseases through the analysis of cellular and subcellular activities. The company aims to shorten drug discovery timelines and reduce costs while utilizing advanced cellular models and technologies.Brain specific drug delivery
Brain specific drug deliverySiddu K M
油
This document discusses drug delivery to the brain and strategies to overcome the blood-brain barrier. It provides a brief history of the discovery of the blood-brain barrier by Paul Ehrlich and Edwin Goldman. It then describes the anatomy and functions of the blood-brain barrier and diseases related to it. The document outlines both invasive and non-invasive strategies that have been developed and researched to more effectively deliver drugs to the central nervous system, including the use of prodrugs, nanoparticles, and liposomes.Imaging biomarkers in Clinical trials
Imaging biomarkers in Clinical trialsAnke Maertens
油
This document discusses the role of icometrix in utilizing quantitative MRI biomarkers to improve clinical trials and patient monitoring for neurological disorders. It highlights the importance of standardized imaging data and the company's experience in providing reliable and objective measures for conditions such as multiple sclerosis and Alzheimer's disease. The future of personalized medicine and digital health is emphasized, showcasing how advanced imaging techniques can enhance treatment decisions and trial efficiency.Building an informatics solution to sustain AI-guided cell profiling with hig...
Building an informatics solution to sustain AI-guided cell profiling with hig...Ola Spjuth
油
This document discusses building an informatics solution to support AI-guided cell profiling using high-content microscopy imaging. The research group aims to accelerate drug discovery using AI and intelligent experimental design. Their goal is to build pipelines of containerized services and workflows to continuously process imaging data, train models, and design new experiments in an automated and scalable manner. This will enable data-driven science through predictive modeling and closing the loop between data generation, analysis, and experimentation.Human blood brain barrier
Human blood brain barrierPete Shuster
油
The document discusses a human blood-brain barrier (BBB) model characterized with primary human cells and engineered hydrogels to mimic the in vivo extracellular matrix. It highlights the importance of stiffness, customizable features, and high-throughput screening capabilities. Additionally, it details the optimization of protocols for assessing drug permeability and toxic assays in the BBB model.Poster sot 2015_am_final
Poster sot 2015_am_finalPete Shuster
油
This document discusses the effects of neurotoxins on neural maturation stages, highlighting the importance of metabolomic profiling to assess developmental neurotoxicity (DNT) using human stem cell-derived neural models. It emphasizes the need for in vitro methods that use relevant cellular systems to study chemical toxicity, revealing that neural progenitors are more vulnerable to bis-1, a known neurotoxin. The findings suggest that neuron-astrocyte co-cultures better represent brain tissue and provide essential insights into DNT through neurite outgrowth and metabolomic analysis.More Related Content
Similar to Neuromics' Short Overview (20)
Characterization of novel human blood-brain barrier (hCMEC/d3) cell line
Characterization of novel human blood-brain barrier (hCMEC/d3) cell line Debanjan (Deb) Das
油
The document discusses the development and characterization of a novel human blood-brain barrier (BBB) cell line, hCMEC/D3, which aims to enhance CNS drug screening. It outlines the importance of the BBB in drug development, the properties of the hCMEC/D3 cell line, and preliminary studies on its transport and permeability characteristics. The findings indicate that hCMEC/D3 retains key functionalities of BBB, suggesting its potential as a reliable in vitro model for testing pharmaceutical compounds.Poster BrainPlotting SEISC 2017 "Prediction of Human PK data based on innovat...
Poster BrainPlotting SEISC 2017 "Prediction of Human PK data based on innovat...Nicolas Perriere
油
Brainplotting specializes in pharmacokinetics studies of the human brain using a proprietary brain exposure prediction model (BEP). This model leverages primary human in vitro tools to predict in vivo drug concentrations, utilizing physiological models to assess BBB permeability and transport mechanisms. Collaborating with academic partners, the company validates its predictive models using various diseases and drug transport studies.The Blood-Brain Barrier in Neurological Disease
The Blood-Brain Barrier in Neurological DiseaseEvan Wehr
油
The document discusses the blood-brain barrier (BBB) and its implications in neurological diseases, focusing on research conducted using div-BBB cartridges to simulate BBB conditions in vitro. The study found that different levels of stretch in the cartridges affected the permeability of astrocyte cells, confirming that the 0% and 79% stretched cartridges had distinct crossing capabilities. Additionally, recommendations for future studies and enhancements to testing methodologies are provided, aiming to further understand BBB dynamics."Bedside to Bench" in Drug Discovery
"Bedside to Bench" in Drug DiscoveryPete Shuster
油
The proteosep速 2D protein microarray module facilitates drug discovery by providing clinically relevant data early in the clinical trial process, enabling the identification of high probability targets and patient autoantibody signatures. It is designed for various applications including biologics and biosimilars development, with a focus on using real patient samples to generate unique insights. The microarray can efficiently differentiate patient populations and identify candidate biomarkers for further analysis, supporting disease monitoring and treatment response assessments.Neuromics Presentation V4
Neuromics Presentation V4Pete Shuster
油
The document outlines tools and capabilities for cell-based assays and gene expression analysis in early-phase drug discovery, emphasizing the use of physiologically relevant primary human, rat, and mouse cells to improve in vitro screening, reduce animal model use, and lower costs. It highlights the expertise of Neuromics in supporting pharmaceutical and biotechnology researchers with technical support, protocols, and reproducibility. Examples of applications include neurogenesis, neuronal differentiation, and compound screening using human neural progenitor kits and various assay methodologies.OncoPrime - Neuro
OncoPrime - Neuro Rachna Goyal
油
The document discusses the Onco-Neuroprime TM platform developed by Saarum Sciences for phenotypic drug and biomarker discovery in high grade glioma, highlighting the use of 3D neurospheres derived from patient tumors for drug screening. It presents various assays and characterizations performed on glioma samples, as well as the advantages of using this platform over traditional 2D cell lines. Additionally, it provides insights into the diversity of brain cancer subtypes and the biobank's inventory of patient samples.Central nervous system drug discovery and challenges.pptx
Central nervous system drug discovery and challenges.pptxGaurav Pandey
油
CNS drug discovery is a complex and challenging process due to the intricate nature of neurological disorders and the presence of the blood-brain barrier (BBB), which limits drug penetration. The development of effective therapies faces hurdles such as high failure rates in clinical trials, off-target side effects, and the long timelines required for safety and efficacy testing. Additionally, the complex pathophysiology of CNS diseases makes target identification difficult. Primary Cell e Newsletter Issue 18 (jun 2016) Cell Applications
Primary Cell e Newsletter Issue 18 (jun 2016) Cell ApplicationsDaniel Schroen, PhD
油
The document discusses a study on the accumulation of Alzheimer's disease-associated amyloid-硫 proteins at the blood-brain barrier, leading to cerebral amyloid angiopathy. It highlights the utility of pre-screened bovine brain microvascular endothelial cells (BBMEC) for researching endothelial cell signaling pathways and drug discovery. Additionally, it mentions the significance of using integration-free human induced pluripotent stem cells (iPSCs) to avoid genetic integration issues when studying cell behavior related to the blood-brain barrier.Jem neuroscience special_issue
Jem neuroscience special_issueElsa von Licy
油
The document summarizes recent publications from The Journal of Experimental Medicine focusing on neuroscience. It highlights several studies: one finding that monocyte-derived macrophages initiate myelin destruction in multiple sclerosis, while microglia-derived macrophages clear debris; another activating B-RAF kinase to promote axon regeneration after nerve injury; and one showing that blocking interleukin-21 reduces brain injury following stroke in mice. It also summarizes studies on retinal thinning in frontotemporal dementia and targeting neurovascular pathology in Alzheimer's disease models.A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...InsideScientific
油
The document discusses advancements in using PET/CT imaging for image-guided neurointerventions, emphasizing the delivery and clearance of therapeutic agents to the brain. It compares various delivery methods, including systemic, intra-arterial, and intracerebral routes, highlighting their pros and cons related to effectiveness and invasiveness. Furthermore, it reviews historical data and current studies on the efficacy of these methods, particularly focusing on intra-arterial therapy combined with blood-brain barrier modulation.UCSF Hyperpolarized MR #8-2: Neurological (2019)
UCSF Hyperpolarized MR #8-2: Neurological (2019)Peder Larson
油
The document discusses the integration of hyperpolarized magnetic resonance (MR) into biomedical research focusing on neurological disorders such as Alzheimer's, traumatic brain injury, and multiple sclerosis. It highlights preclinical findings about brain metabolism, inflammation, and cognitive deficits, as well as suggests potential future applications and ongoing clinical trials. Key challenges in utilizing hyperpolarized MR for studying the brain's metabolic processes and monitoring treatment are also addressed.Towards automated phenotypic cell profiling with high-content imaging
Towards automated phenotypic cell profiling with high-content imagingOla Spjuth
油
This document outlines an initiative at Uppsala University to enhance drug discovery through automated phenotypic cell profiling using high-content imaging and AI. The research aims to integrate automation and intelligent experimental design to speed up the hypothesis generation, testing, and data analysis processes in biological labs. Key technologies mentioned include automated labs, advanced imaging techniques, and a focus on data-driven science to optimize drug development and safety assessments.The Blood Brain Barrier, A Bridge Too Far
The Blood Brain Barrier, A Bridge Too FarLaurent Lecanu
油
The document presents challenges in targeting the brain, focusing on the blood-brain barrier (BBB) as a significant barrier to drug delivery due to its unique structure and restrictive characteristics. It highlights the complexities of drug permeability, the role of various transporters, and emerging nanoparticle technologies for overcoming these challenges. Additionally, it addresses the lack of knowledge and integration regarding BBB in pharmaceutical research and development, emphasizing the need for further exploration and mapping in drug design.Several methods making drugs overcome blood-brain barier obstacle .
Several methods making drugs overcome blood-brain barier obstacle .Abeer Abd Elrahman
油
The blood-brain barrier represents a major obstacle to delivering drugs to the central nervous system. Several methods have been attempted to overcome this barrier, including using exosomes, prodrugs, polymer encapsulation, receptor-mediated transport, modifying surface charge, and transiently disrupting the barrier using chemical agents, focused ultrasound, or magnetic fields. Encapsulating drugs within biodegradable polymers like PLGA allows them to accumulate in brain tumors at higher levels compared to healthy brain tissue.Advances-in-cancer-research.pdf
Advances-in-cancer-research.pdfssuser54a9d9
油
The document discusses several technologies and approaches for advancing cancer research by addressing limitations of current methodologies. It describes a new technology called the NanoString GeoMx Digital Spatial Profiler that enables high-plex spatial analysis of biological samples using fluorescently labeled antibodies. It also discusses the development of customized morphology markers to help users select biologically relevant regions of interest for analysis. Additionally, it covers several other areas of cancer research including the use of stem cells for treatment, automated counting of immune cells, development of drug antibodies and therapies targeting GPCRs, and blocking immune checkpoint molecules to stimulate anti-tumor immune responses.Neural surface antigens from basic biology towards biomedical applications 1s...
Neural surface antigens from basic biology towards biomedical applications 1s...tredeitio
油
Neural surface antigens from basic biology towards biomedical applications 1st Edition Pruszak
Neural surface antigens from basic biology towards biomedical applications 1st Edition Pruszak
Neural surface antigens from basic biology towards biomedical applications 1st Edition PruszakHCS for brain disorders / HCS Pharma at B4B mars 2018
HCS for brain disorders / HCS Pharma at B4B mars 2018HCS Pharma
油
HCS Pharma is a biotechnology company focused on high-content screening (HCS) and cellular imagery to facilitate drug discovery and repurposing, especially for brain disorders. Their innovative methods allow for the identification of new drug applications and mechanisms of diseases through the analysis of cellular and subcellular activities. The company aims to shorten drug discovery timelines and reduce costs while utilizing advanced cellular models and technologies.Brain specific drug delivery
Brain specific drug deliverySiddu K M
油
This document discusses drug delivery to the brain and strategies to overcome the blood-brain barrier. It provides a brief history of the discovery of the blood-brain barrier by Paul Ehrlich and Edwin Goldman. It then describes the anatomy and functions of the blood-brain barrier and diseases related to it. The document outlines both invasive and non-invasive strategies that have been developed and researched to more effectively deliver drugs to the central nervous system, including the use of prodrugs, nanoparticles, and liposomes.Imaging biomarkers in Clinical trials
Imaging biomarkers in Clinical trialsAnke Maertens
油
This document discusses the role of icometrix in utilizing quantitative MRI biomarkers to improve clinical trials and patient monitoring for neurological disorders. It highlights the importance of standardized imaging data and the company's experience in providing reliable and objective measures for conditions such as multiple sclerosis and Alzheimer's disease. The future of personalized medicine and digital health is emphasized, showcasing how advanced imaging techniques can enhance treatment decisions and trial efficiency.Building an informatics solution to sustain AI-guided cell profiling with hig...
Building an informatics solution to sustain AI-guided cell profiling with hig...Ola Spjuth
油
This document discusses building an informatics solution to support AI-guided cell profiling using high-content microscopy imaging. The research group aims to accelerate drug discovery using AI and intelligent experimental design. Their goal is to build pipelines of containerized services and workflows to continuously process imaging data, train models, and design new experiments in an automated and scalable manner. This will enable data-driven science through predictive modeling and closing the loop between data generation, analysis, and experimentation.More from Pete Shuster (12)
Human blood brain barrier
Human blood brain barrierPete Shuster
油
The document discusses a human blood-brain barrier (BBB) model characterized with primary human cells and engineered hydrogels to mimic the in vivo extracellular matrix. It highlights the importance of stiffness, customizable features, and high-throughput screening capabilities. Additionally, it details the optimization of protocols for assessing drug permeability and toxic assays in the BBB model.Poster sot 2015_am_final
Poster sot 2015_am_finalPete Shuster
油
This document discusses the effects of neurotoxins on neural maturation stages, highlighting the importance of metabolomic profiling to assess developmental neurotoxicity (DNT) using human stem cell-derived neural models. It emphasizes the need for in vitro methods that use relevant cellular systems to study chemical toxicity, revealing that neural progenitors are more vulnerable to bis-1, a known neurotoxin. The findings suggest that neuron-astrocyte co-cultures better represent brain tissue and provide essential insights into DNT through neurite outgrowth and metabolomic analysis.CELL-a-brate-Knowing Your Assays
CELL-a-brate-Knowing Your AssaysPete Shuster
油
The document outlines expertise in providing human stem and primary cells for various applications including drug discovery, toxicity assays, and gene expression analysis. It details specific studies conducted on cell cultures and highlights the range of available cell types and services offered, including a money-back guarantee for cell effectiveness. For further inquiries, contact information for the CEO is provided.Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Pete Shuster
油
The document summarizes the regenerative medicine field based on a report from the Alliance for Regenerative Medicine, including an overview of major industry players and subsectors, clinical trials and products in development, financial performance and investments in 2013, and insights from a panel discussion on key areas of focus. It analyzes trends in cell and gene therapies, areas attracting pharmaceutical investment, and challenges facing the commercialization of regenerative medicine technologies and therapies.Vitro Biopharma-Business & technical overview 12 9-13
Vitro Biopharma-Business & technical overview 12 9-13Pete Shuster
油
This document provides a technical and business overview of Vitro Biopharma. It summarizes their stem cell products focusing on mesenchymal stem cells, introduces their management team and partners, describes their proprietary MSC growth medium MSCGro which supports faster growth than competitors' media, and outlines their research in areas like osteoporosis drug discovery using cell-based assays. It also reviews their intellectual property strategy and regenerative medicine market opportunities.Neuron Glial Interactions
Neuron Glial InteractionsPete Shuster
油
The document discusses neuron-glia interactions, focusing on the various roles of glial cells in the nervous system, including their impact on neuronal differentiation, survival, and synapse formation. It highlights the types of glia, methods of identification, and their functions such as myelination, guiding neuronal migration, and secreting factors essential for synaptic activity. Additionally, it covers the importance of glia in metabolic support and signaling within the brain, detailing how they contribute to both normal and pathological processes.Optimized Protocol for Sorting Cells
Optimized Protocol for Sorting CellsPete Shuster
油
This document describes an optimized protocol that enables the co-detection of cluster of differentiation (CD) surface antigens on fixed, permeabilized neural cell populations through combined flow cytometric analysis of both surface and intracellular antigens. This reveals surface molecule markers of human neuropoiesis.Biopharma musculoskeletal disorders_draft 6-30-2013 jm edits
Biopharma musculoskeletal disorders_draft 6-30-2013 jm editsPete Shuster
油
This document discusses potential cell-based assays for drug discovery related to musculoskeletal disorders using human mesenchymal stem cells (MSCs). Specifically, it describes MSCs derived from umbilical cord blood that are phenotypically stable and can differentiate into osteoblasts, chondrocytes, and fibroblasts. Potent media are also described that allow expansion of these cells in a manner suitable for high-throughput screening. Images demonstrate differentiation of MSCs and growth of fibroblasts over multiple passages. The document argues that these cells and media provide a cost-effective alternative to induced pluripotent stem cells for developing cell-based assays.Biopharma musculoskeletal disorders_4-30-2013
Biopharma musculoskeletal disorders_4-30-2013Pete Shuster
油
The document outlines new assays for drug discovery in musculoskeletal disorders using potent umbilical cord blood-derived human mesenchymal stem cells. It emphasizes the advantages of using these cells and specialized media, highlighting their stability, cost-effectiveness, and ability to support high-throughput screening. The evaluation process for developing custom assays is detailed, including milestones and scalability considerations.Essen bioscience neuromics 9_17_12
Essen bioscience neuromics 9_17_12Pete Shuster
油
The document discusses the CellPlayer Neurotrack assay, a user-friendly software compatible with various neuronal cell types that enables real-time quantification of neurite dynamics. It highlights its advantages, such as label-free imaging, high-definition imagery, and the ability to monitor cytotoxicity and neurite outgrowth simultaneously. The assay has been validated with multiple cell types and is designed for automated data acquisition and integrated metric calculations.Arun A Neuromics Hca Hts Overview V3 04 26 2011
Arun A Neuromics Hca Hts Overview V3 04 26 2011Pete Shuster
油
1) ArunA Biomedical produces three neural cell products from different sources - STEMEZTM hNP1TM from human embryonic stem cells, STEMEZTM hN2TM from human embryonic stem cells, and STEMEZTM iPS-NP1TM from human induced pluripotent stem cells - for use in high-throughput screening and high-content analysis assays.
2) The document demonstrates that all three neural cell products can be used to measure ATP levels in a high-throughput screening assay and evaluate neurite outgrowth in a high-content analysis assay to test neurotoxicity and neuronal differentiation.
3) Both hNP1TM and hN2TM neural cells differentiated effectively inApoptosis
ApoptosisPete Shuster
油
The document discusses cytometry techniques for analyzing apoptosis. It describes measuring mitochondrial changes, caspase activation, and DNA fragmentation to identify and quantify apoptotic cells. Specific techniques summarized include using fluorescent probes to detect mitochondrial membrane potential loss, caspase activation via cleavage of targets like PARP, and DNA strand breaks.Ad
Recently uploaded (20)
Science Holiday Homework (interesting slide )
Science Holiday Homework (interesting slide )aryanxkohli88
油
science holiday homework
good for childrenPrimary and Secondary immune modulation.pptx
Primary and Secondary immune modulation.pptxdevikasanalkumar35
油
Primary and secondary immune modulation
Introduction to solar panel and about solar on grid
Introduction to solar panel and about solar on gridvardhanreddypuli06
油
This ppt is about the solar panels and its type called solar on grid.This ppt has some animated slides in it about the future of solar on grid and how it works,what are the components of solar on grid and where we use them and how we use them in better way .so that it becomes an environment friendly for usGBSN__Unit 2 - Control of Microorganisms
GBSN__Unit 2 - Control of MicroorganismsAreesha Ahmad
油
Microbiology for Nursing students - According to New PNC course curriculum - 2025
CULTIVATION - HARVESTING - PROCESSING - STORAGE -.pdf
CULTIVATION - HARVESTING - PROCESSING - STORAGE -.pdfNistarini College, Purulia (W.B) India
油
This presentation offers a brief idea about the cultivation, processing, storage and marketing of medicinal plants for the health care practices in sustainable health. The role of different factors has been assessed for the same.GBSN_ Unit 1 - Introduction to Microbiology
GBSN_ Unit 1 - Introduction to MicrobiologyAreesha Ahmad
油
Microbiology for Nursing students - According to New PNC course curriculum - 2025Scientific Instruments Market (PPT) (Satiyam).pptx
Scientific Instruments Market (PPT) (Satiyam).pptxExpert Market Research
油
The global scientific instruments market reached USD39.94billion in 2024 and is projected to grow at a 4.50% CAGR, hitting around USD62.03billion by 2034.This surge is driven by increasing R&D investments in pharmaceuticals, biotech, environmental testing, and industrial analytics. Demand for high-precision analytical and clinical analyzers supports growth across academic, industrial, and government sectors, fueled by stricter regulations and scientific collaborations worldwide.Deconstruction Analysis The adventure of devil's foot by Sir Arthur Conan Doyle
Deconstruction Analysis The adventure of devil's foot by Sir Arthur Conan Doylestaverechard
油
Arthur Conan Doyle (1859-1930) was a Scottish writer and physician who is widely recognized as the creator of the legendary detective character, Sherlock Holmes. Born in Edinburgh, Doyle studied medicine at the University of Edinburgh, where he began writing short stories in his spare time. Although he initially worked as a doctor, his name became widely known when he published the Sherlock Holmes stories, starting with A Study in Scarlet (1887). (Sakula,1997). Sherlock Holmes and Dr. Watson are on holiday in Cornwall, seeking rest for Holmes. They become involved in a mysterious case involving the deaths and madness of the Tregennis family. One sister dies with a terrified expression, while the two brothers are found insane. Holmes discovers that a rare West African poison called "Devils Foot" was used, which affects the mind. The murderer is ultimately revealed to be Dr. Leon Sterndale, an explorer and relative of the family, who takes justice into his own hands. Pathophysiology_Unit1_BPharm CELL INJURY
Pathophysiology_Unit1_BPharm CELL INJURYKRUTIKA CHANNE
油
Basic principles of Cell injury and Adaptation:
Introduction, definitions, Homeostasis, Components and Types of Feedback systems, Causes of cellular injury, Pathogenesis (Cell membrane damage, Mitochondrial damage, Ribosome damage, Nuclear damage), Morphology of cell injury Adaptive changes (Atrophy, Hypertrophy, hyperplasia, Metaplasia, Dysplasia), Cell swelling, Intra cellular accumulation, Calcification, Enzyme leakage and Cell Death, Acidosis &Alkalosis, Electrolyte imbalance
International Journal of Pharmacological Sciences (IJPS)
International Journal of Pharmacological Sciences (IJPS)journalijps98
油
Call for Research Articles.!!!
FREE PUBLICATION CHARGES
International Journal of Pharmacological Sciences (IJPS)
Webpage URL : https://www.wireilla.com/medical/IJPS/index.html
Wikicfp Url:http://www.wikicfp.com/cfp/servlet/event.showcfp?eventid=181292©ownerid=33993
Authors are invited to submit papers through the Journal Submission System
http://allcfps.com/wireilla/submission/index.php
Submission Deadline : June 17, 2025
Contact Us
Here's where you can reach us : journalijps98@gmail.com or ijpsjournal@wireilla.comAd
Neuromics' Short Overview
- 1. CHARACTERIZED, TESTED AND DISCOVERY READY FOR RESULTSYOU CANTRUST AND UNDERSTAND Solutions Designed for Drug Discovery and Basic Research www.neuromics.com
- 2. OUR CORNERSTONE: HUMAN PRIMARY CELLS AND 3-D TISSUE MODELS, DEFINED MEDIA AND FBS 2 and 3-D Cell Based Assays >250 peer Reviewed Publications 3-DTissue-Like Models Primary Human Neuron,Astrocytes and Microglia Primary Human Endothelial Cells and Pericytes Cancer Associated Fibroblasts andTumor Cells Human MSCs and Derived Cells Primary Antibodies & Markers Apoptosis Kits GeneTools Proteins and Growth Factors Protein Generation & Purification FBS, Media & Culturing Products
- 3. RESULTSYOU CAN TRUST AND UNDERSTAND 3rd Party Service For Customer Feedback Neuromics review summary Sample Reviews: Ravi D.on BirdEye We have ordered Brain derived Endothelial Cells or BECs.We could not find these in different companies, particularly from multiple donors. Overall, we are happy with the products. Olesya P.on BirdEye We bought a large order of FBS from Neuromics. Our experience with their customer service was great.They offered us the best price and worked with us on any issue issues that came up on our side. Jiehua Z.on BirdEye We ordered the cells, medium and related culture product. Fast ordering and delivery procedure, and nice technique support.The cells grew well as described and we can easily expand them. HBMECs Stained with CD146
- 4. HUMAN PRIMARY CELLS Neurons, Astrocytes, Schwann Cells and Microglia Endothelial Cells Fibroblasts, CAFs and Cancer Cells Human Brain Microvascular Endothelial Cells stained with CD146
- 5. HUMAN BBB MODEL TEST APPLICATIONS Permeability Studies -Compounds, Oligos and Small Molecules : General Procedure 3D Blood Brain Barrier models are thawed and cultured for 4 days to establish viable barrier as measured by transendothelial electrical resistance (> 150 立 x cm2). The test compound and fluorescent probe are added and the cultures are returned to incubate for designated times. If assessment of alterations to BBB permeability due to drug treatment is required, fluorescent dextran conjugate is added to wells Media is sampled for quantitation of test articles by UPLC, and for quantification of fluorescent probe by plate reader Apparent permeability is calculated Bottom Figure:Alterations in apparent permeability of blood brain barrier due to drug treatment. Data presented as mean 賊 SEM x 10-6 cm/s. * Indicates p<0.05 for Fishers LSD t-test comparisons to DMSO controls in a post hoc analysis following two-way ANOVA. Data Courtsey ofVisokol ;
- 6. CANCER ASSOCIATED FIBROBLASTS AND GFP- RFP EXPRESSING CARCINOMA CELL LINES Gastric Carcinoma 87 Top image: RFP Expressing Gastric Carcinoma 87 Cells cat no. TR02-RFP Glioblastoma Prostate Carcinoma Cells (DU 145) Renal Adenocarcinoma Cells (ACHN) Bottom image: GFP-Expressing Renal Adenocarcinoma Cells cat no.TR04-GFP
- 7. Neuromics is the U.S. Distributor for IBA Lifesciences Solutions cell selection & expansion. exosome isolation. protein production & assays.
- 8. Fetal Bovine Serum (FBS) Manufactured under the strictest guidelines Triple filtered, single Use filters Lowest price anywhere Compare and save
- 9. ANTIBODIES Antibodies for many research areas: Neuroscience Apoptosis Cancer Angiogenesis Diabetes and Obesity Immune Response Stem Cell Research Musculoskeletal Disease Image: PGP9.5 (cat no. RA12103) staining of rat DRGs (Dilution 1:500)
- 10. Phone: 952-374-616 Fax: 612-677-3976 Email: david@neuromics.com for orders and tech questions We welcome your input, feedback and questions: Pete Shuster-CEO and Owner Direct Phone: 612-801-1007 Email: pshuster@neuromics.com 5235 W 74th Street Suite 8 Edina, MN, 55439 www.neuromics.com Find us on Get Exclusive Discounts and Special offers New Product Updates Researcher Insights The Latest in Neuroscience News